OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/12/2025
Voltar para busca
Dado oficial do USPTO
SANWAY GENE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10
Data de depósito
05/01/2024
Data de registro
21/01/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
21/01/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
CN
Examinador
LAM, HAI-LY HUYNH
Unidade examinadora
N10
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of a stylized DNA double-helix inside a square background, and to the right of the design is the stylized word "SANWAY" and "GENE" with four Chinese characters arranged in two lines.
Titulares e representantes
Titulares
Sanway Gene Tech. Inc.
Representantes
Yue (Robert) Xu Apex Attorneys at Law, LLP
Classificação técnica
Classes Nice
Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Intravenous fluids used for rehydrationnutrition and the delivery of pharmaceutical preparations; antibiotics; vaccine preparations; pharmaceutical preparations for treating allergies; preparations for detecting genetic predispositions for medical purposes; diagnostic preparations for medical purposes; diagnostic reagents for medical use; genetic identity tests comprised of reagents for medical purposes; reagent paper for medical purposes; reagents for medical use; biological preparations for medical purposes for the prevention and treatment of disorders of the digestive systemblood systemthe nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemof the genitourinary systemfor the prevention and treatment of infectious diseasesviral diseasesinflammatory disordersfor use in dermatologyoncologyhematologytissue and organ transplantationophthalmology and for the treatment of gastroenterological disorders; diagnostic biomarker reagents for medical purposes; immunoassay reagents for medical use; enzyme preparations for medical purposes; reagents for use in medical genetic testing; mineralvitaminnutritionally enhanced water for medical purposes; medicated water for the treatment of illnesses attributed to insufficient cellular energy; medicated water for the treatment of allergiescoughcoldfluheadachepain; medicated water for the treatment of infectious diseasesskin diseases and conditionsinternal tissue diseases and conditions; medicated water for the treatment of painnausea and muscle spasms; medicated water-based solutions for treating skin infections and skin conditions; medicated water for the treatment of gastrointestinal disorders; demineralised water for medical purposes; diagnostic kits comprised of medical diagnostic reagents for use in disease testinghealth monitoringpredictive and preventive medicine in the fields of detecting diseases related to cancerinfectious diseasesviral diseaseshereditary diseasesinflammatory disordersoncological disorders of the digestive systemblood systemreproductive systemthe nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary system; purified biochemical medical diagnostic reagentsprotein arraysenzymesfluorescent dyes for use as reagents in medical diagnostic applications; biological preparations for the diagnosis of disorders of the digestive systemblood systemthe nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary system and for the diagnosis of cancerhereditary diseasesinfectious diseasesviral diseasesinflammatory disordersdermatological conditionsoncological diseasesblood diseasesconnective tissue disordersophthalmic diseasesgastroenterological disorders; biological preparations for the treatment of disorders of the digestive systemblood systemthe nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary system and for the treatment of cancerhereditary diseasesinfectious diseasesviral diseasesinflammatory disordersdermatological conditionsoncological diseasesblood diseasesconnective tissue disordersophthalmic diseasesgastroenterological disorders; biochemical drugs for the diagnosis of disorders of the digestive systemblood systemthe nervous systemthe immune systemthe cardiovascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary system and for the diagnosis of cancerinfectious diseasesviral diseaseshereditary diseasesinflammatory disordersdermatological conditionsoncological diseasesblood diseasesconnective tissue disordersophthalmic diseasesgastroenterological disorders; biochemical drugs for the treatment of disorders of the digestive systemblood systemthe nervous systemthe immune systemthe cardiovascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary system and for the treatment of cancerinfectious diseasesviral diseaseshereditary diseasesinflammatory disordersdermatological conditionsoncological diseasesblood diseasesconnective tissue disordersophthalmic diseasesgastroenterological disorders; antibiotic tablets; allergy tablets; chemico-pharmaceutical preparations in the nature of biological indicatorsin-vivo diagnostic agentsin-vitro diagnostic reagents all for the diagnosismonitoringtreatment and prevention of cancerinflammatory disordersoncological disordersinfectious diseaseshereditary diseasesviral diseasesdiseases related to the digestive systemblood systemthe nervous systemthe immune systemthe cardiovascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary system; chemical preparations in the nature of biological indicatorsin-vivo diagnostic agentsin-vitro diagnostic reagents all for the diagnosismonitoringtreatment and prevention of cancerinflammatory disordersoncological disordersinfectious diseaseshereditary diseasesviral diseasesdiseases related to the digestive systemblood systemthe nervous systemthe immune systemthe cardiovascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary system; antibiotic ointments; anti-inflammatory ointments; medicated ointments for treating dermatological conditions; ointments for pharmaceutical purposesanti-itch ointmentshemorrhoidal ointments
Classe 10
Surgical apparatus and instruments; apparatus for use in medical analysisapparatus for blood analysisbody composition analyzersapparatus for analyzing and detecting bacteria and virusesapparatus for analyzing and detecting DNA and RNAapparatus for analyzing and detecting genesapparatus for analyzing blood vesselsapparatus for immunoassay analysisapparatus for organ and tissue cavitation detectingapparatus for medical imaging analysis; diagnostic apparatus for medical purposes in the nature of medical diagnostic imaging apparatusfor use with computer displays and computer monitors and for use with recorded computer operating software and recorded smartphone operating softwareall sold as a unit; body composition analyzers for medical purposes; apparatus for DNA and RNA testing for medical purposes; analysers for bacterial identification for medical purposes; apparatus used in implementing diagnosis tests designed to detect the abnormal prion protein; genetic testing apparatus for medical purposes; medical equipmentdevices for bioanalysis of pathogens in the nature of reagent cartridges for sample preparationnucleic acid purificationnucleic acid amplification and electrochemical detection all for medical diagnostic purposes; gene testing medical apparatus for identification of genus specific and species specific DNA and RNA sequences; immunochemical testing apparatus for medical use; immunochemical medical diagnostic testing apparatus for detecting and measuring antibody levels; medical diagnostic apparatus for testing for viruses; medical diagnostic apparatus for testing DNA and RNA samples
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
19/11/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
19/11/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
29/08/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/08/2025
FIMP
FINAL DISPOSITION PROCESSED
07/08/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
22/04/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
21/01/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
21/01/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/12/2024
PUBO
PUBLISHED FOR OPPOSITION
03/12/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27/11/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/11/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/10/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/10/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/10/2024
RFNT
REFUSAL PROCESSED BY IB
09/09/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
19/08/2024
RFRR
REFUSAL PROCESSED BY MPU
17/08/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/08/2024
CNRT
NON-FINAL ACTION WRITTEN
07/08/2024
DOCK
ASSIGNED TO EXAMINER
01/08/2024
MAFR
APPLICATION FILING RECEIPT MAILED
02/07/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/07/2024
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
28/06/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
20/06/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SANWAY GENE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.